ODDB.org: Open Drug Database

Novartis Pharma Schweiz AG - Xolair 300 mg/2 ml, Injektionslösung in einer Fertigspritze

Swissmedic Registration	68030	Sequence	03
Product name	Xolair 300 mg/2 ml	Description	Injektionslösung in einer Fertigspritze
ATC-Classification	R03DX05	ATC-Description	Omalizumab
Introduction of Sequence	03.07.2024

Composition

omalizumabum 300.00 mg, arginini hydrochloridum, histidini hydrochloridum monohydricum, histidinum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 2.00 ml.

Packungsbestandteile

Galenic Form

Injection solution in prefilled syringe

Excipiens

Active Agent	Dose
Omalizumab	300mg / 2ml

BAG: Active Agent	Dose
Omalizumab	300 mg

Inactive agents
Arginine Hydrochloride
Histidin Hydrochloride Monohydrate
Histidine
Polysorbatum 20

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
003		751.66	833.90	B	SL	No

2025	©ywesee GmbH